Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein binding
Authors:
- I. Odar-CederlöfIOI. Odar-Cederlöf
- O. BorgåOBO. Borgå
- 1 January 1974
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 7 (1) , 31-37
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recent myocardial infarction and the conduction system. A clinico-pathological correlation.Heart, 1972
- Micromethod for the Determination of Diphenylhydantoin in Plasma and Cerebrospinal Fluid—A Comparison Between a Gas Chromatographic and a Spectrophotometric MethodScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Diphenylhydantoin Metabolism in UremiaNew England Journal of Medicine, 1971
- Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal FunctionNew England Journal of Medicine, 1971
- ABNORMAL PHARMACOKINETICS OF PHENYTOIN IN A PATIENT WITH URÆMIAThe Lancet, 1970
- Kinetics of Diphenylhydantoin Disposition in ManChemical and Pharmaceutical Bulletin, 1970
- Volume Terms in PharmacokineticsJournal of Pharmaceutical Sciences, 1969
- Effect of Mode of Administration on Drug Distribution in a Two-Compartment Open SystemJournal of Pharmaceutical Sciences, 1969
- Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic EffectsCirculation, 1968
- The Electrophysiological Properties of Diphenylhydantoin Sodium as Compared to Procaine Amide in the Normal and Digitalis-Intoxicated HeartCirculation, 1967